Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Firebrick Pharma Limited ( (AU:FRE) ) has issued an announcement.
Firebrick Pharma Limited has successfully launched its Nasodine Nasal Spray in Singapore, expanding its availability to 125 Guardian pharmacies and gaining support from local doctors. The company also reported significant growth in online sales in the US, driven by marketing strategies and promotions, indicating strong market adoption and positioning for future growth.
More about Firebrick Pharma Limited
Firebrick Pharma Limited operates in the pharmaceutical industry, focusing on the development and distribution of innovative healthcare products. Their primary product is Nasodine Nasal Spray, a povidone-iodine nasal spray, which targets retail and medical markets.
YTD Price Performance: 33.33%
Average Trading Volume: 199,474
Technical Sentiment Signal: Sell
See more data about FRE stock on TipRanks’ Stock Analysis page.